(Shanghe Branch) with an annual output of 23.3 tons of pharmaceutical raw materials and ten kilograms of pharmaceutical raw materials pilot platform project The first public announcement of environmental impact assessment

Jinan APTC Pharmaceutical Technology Co., Ltd (Shanghe Branch) with an annual production capacity of 23.3 tons of pharmaceutical raw materials and ten kilograms of pharmaceutical raw materials pilot platform project

Environmental impact assessment of the first public information

According to the Environmental Impact Assessment Law of the People's Republic of China, Measures for Public Participation in Environmental Impact Assessment (Decree No. 4 of the Ministry of Ecological Environment) and relevant provisions of environmental impact assessment of construction projects, the construction of the project and environmental impact assessment is publicized in order to broadly understand the public's attitude towards the project and environmental protection opinions and suggestions, and accept public supervision.

First, the name of the construction project and general information

Project Name: Jinan APTC Pharmaceutical Technology Co., Ltd (Shanghe Branch) with an annual output of 23.3 tons of pharmaceutical raw materials and ten kilograms of pharmaceutical raw materials pilot platform project.

Project Overview: Jinan APTC Pharmaceutical Technology Co., Ltd. was founded by Dr. Peng Lizeng, Jinan 5150 talents (the fourth batch), which is a new specialized pharmaceutical and chemical enterprise specializing in the research, technology transfer, new drug declaration, production and sales of chemical raw materials, pharmaceutical intermediates and fine chemicals, and it is an innovative private enterprise in Shandong Province, and a high-tech incubation enterprise. In order to meet the market demand and promote the development of enterprises, Jinan Aisi Pharmaceutical Technology Co., Ltd. plans to invest 21.5 million yuan, the construction of an annual output of 23.3 tons of pharmaceutical raw materials and ten kilograms of pharmaceutical raw materials and pharmaceutical pilot platform project. The project is located in Shanghe County, Shandong Province Economic Development Zone, Ke Yuan Road, high-end chemical raw materials industrial park, covers an area of 6124.9m2, building area of 7935.6m2, leasing unused workshop, quality inspection and research and development room, office buildings, warehouses and other structures for construction. After the completion of the project, it is expected that the annual output of pharmaceutical raw materials 23.3 tons (including Rebapatide 5 tons / year, Tadiazolamide 1 ton / year, levofolinic acid calcium 2 tons / year, 15 tons of Tamiflu and Bivalirudin Pentapeptide 0.3 tons / year), and the completion of the ten kilograms of pharmaceutical raw materials pilot platform.

Second, the name and contact information of the construction unit

Construction unit: Jinan APTC Pharmaceutical Technology Co.

Address: Room 2103, Block A, Building 1, Jinan Pharmaceutical Valley, North Section of Gangxing Road, Hi-tech Zone, Jinan, Shandong, China.

Contact Name: Ji Songtao Contact Tel: 15154131653

E-mail: sales@china-aptc.com Postal Code: 250101

Name and contact information of environmental impact assessment organization

Name of EIA Organization: Shandong Guohuan Environmental Protection Technology Co.

Contact person in charge of the project: Mr. Ma

Tel: 18963062803 邮箱:276306445@qq.com

Fourth, the network connection of the public comment form

Link: https://pan.baidu.com/s/1-Tc7r2jHDNCt1Q5-fwT0Xw&shfl=shareset Extract code: 9b78

Or scan the QR code to get it:

V. Main ways of public comments

The public can follow the above link or scan the QR code to download the public opinion form, fill in the completed form and send it to the contact person of the construction unit by e-mail, or directly reflect to the construction unit by phone.

Jinan APTC Pharmaceutical Technology Co.

Public Notice Date: October 22, 2019